I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| classical monocyte | 21 studies | 28% ± 14% | |
| non-classical monocyte | 20 studies | 39% ± 16% | |
| macrophage | 15 studies | 24% ± 6% | |
| monocyte | 12 studies | 27% ± 7% | |
| CD16-positive, CD56-dim natural killer cell, human | 6 studies | 22% ± 4% | |
| endothelial cell | 6 studies | 22% ± 7% | |
| microglial cell | 6 studies | 21% ± 5% | |
| myeloid cell | 6 studies | 30% ± 11% | |
| astrocyte | 6 studies | 29% ± 11% | |
| natural killer cell | 5 studies | 20% ± 3% | |
| endothelial cell of lymphatic vessel | 5 studies | 22% ± 6% | |
| conventional dendritic cell | 4 studies | 32% ± 15% | |
| dendritic cell | 4 studies | 31% ± 21% | |
| epithelial cell | 3 studies | 27% ± 4% | |
| mononuclear phagocyte | 3 studies | 25% ± 8% |
